Jia Liu
Concepts (159)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myxoma virus | 13 | 2017 | 14 | 2.830 |
Why?
| Viral Proteins | 12 | 2017 | 158 | 2.750 |
Why?
| Poxviridae | 4 | 2019 | 6 | 1.790 |
Why?
| Host Specificity | 3 | 2017 | 5 | 0.990 |
Why?
| Genetic Vectors | 4 | 2019 | 139 | 0.890 |
Why?
| Proteins | 3 | 2017 | 376 | 0.870 |
Why?
| Myxomatosis, Infectious | 3 | 2013 | 3 | 0.810 |
Why?
| Virus Replication | 4 | 2016 | 143 | 0.790 |
Why?
| Genetic Therapy | 3 | 2019 | 121 | 0.780 |
Why?
| Oncolytic Viruses | 5 | 2014 | 12 | 0.750 |
Why?
| Genetic Engineering | 2 | 2019 | 27 | 0.710 |
Why?
| Virus Cultivation | 1 | 2019 | 4 | 0.680 |
Why?
| Viral Tropism | 3 | 2013 | 5 | 0.670 |
Why?
| Host-Pathogen Interactions | 2 | 2016 | 143 | 0.590 |
Why?
| Rabbits | 9 | 2018 | 425 | 0.550 |
Why?
| Transcription, Genetic | 1 | 2016 | 418 | 0.500 |
Why?
| Protein Biosynthesis | 1 | 2016 | 273 | 0.480 |
Why?
| Interleukin-15 | 2 | 2014 | 19 | 0.470 |
Why?
| Animals | 22 | 2019 | 14409 | 0.470 |
Why?
| Adenoviridae | 2 | 2008 | 58 | 0.420 |
Why?
| Virulence Factors | 1 | 2011 | 94 | 0.360 |
Why?
| Immunologic Factors | 1 | 2010 | 130 | 0.350 |
Why?
| RNA, Catalytic | 1 | 2008 | 3 | 0.330 |
Why?
| Herpesvirus 1, Human | 1 | 2008 | 15 | 0.330 |
Why?
| Cornea | 1 | 2008 | 62 | 0.330 |
Why?
| Oncolytic Virotherapy | 3 | 2012 | 18 | 0.320 |
Why?
| Dependovirus | 1 | 2008 | 102 | 0.320 |
Why?
| Antiviral Agents | 2 | 2013 | 188 | 0.320 |
Why?
| Cell Line | 5 | 2019 | 1152 | 0.280 |
Why?
| Intracellular Signaling Peptides and Proteins | 3 | 2017 | 151 | 0.260 |
Why?
| Kinetics | 3 | 2012 | 692 | 0.240 |
Why?
| Cell Line, Tumor | 5 | 2017 | 1551 | 0.240 |
Why?
| Mammals | 2 | 2013 | 59 | 0.220 |
Why?
| Evolution, Molecular | 2 | 2013 | 103 | 0.210 |
Why?
| Poxviridae Infections | 2 | 2011 | 4 | 0.190 |
Why?
| Virulence | 2 | 2012 | 196 | 0.190 |
Why?
| Mice | 9 | 2017 | 6428 | 0.190 |
Why?
| Drug Evaluation, Preclinical | 2 | 2019 | 158 | 0.190 |
Why?
| Humans | 15 | 2019 | 54391 | 0.170 |
Why?
| Vero Cells | 1 | 2019 | 44 | 0.170 |
Why?
| Transgenes | 1 | 2019 | 55 | 0.170 |
Why?
| Transduction, Genetic | 2 | 2008 | 50 | 0.170 |
Why?
| Protein Structure, Tertiary | 2 | 2017 | 289 | 0.170 |
Why?
| Survival Analysis | 2 | 2011 | 736 | 0.150 |
Why?
| Recombinant Fusion Proteins | 2 | 2014 | 206 | 0.150 |
Why?
| Cytoplasmic Granules | 1 | 2016 | 24 | 0.140 |
Why?
| HEK293 Cells | 1 | 2017 | 245 | 0.140 |
Why?
| HeLa Cells | 1 | 2017 | 291 | 0.140 |
Why?
| Gene Knockout Techniques | 2 | 2013 | 45 | 0.130 |
Why?
| Interleukin-15 Receptor alpha Subunit | 1 | 2014 | 2 | 0.130 |
Why?
| Stress, Physiological | 1 | 2016 | 194 | 0.130 |
Why?
| RNA-Binding Proteins | 2 | 2013 | 136 | 0.130 |
Why?
| eIF-2 Kinase | 1 | 2013 | 5 | 0.120 |
Why?
| Multigene Family | 1 | 2013 | 54 | 0.120 |
Why?
| DEAD-box RNA Helicases | 1 | 2013 | 35 | 0.110 |
Why?
| Gene Deletion | 2 | 2012 | 293 | 0.110 |
Why?
| Adaptation, Biological | 1 | 2012 | 9 | 0.110 |
Why?
| Antineoplastic Agents | 2 | 2012 | 1300 | 0.110 |
Why?
| Dog Diseases | 1 | 2012 | 11 | 0.110 |
Why?
| Vaccinia virus | 1 | 2012 | 7 | 0.110 |
Why?
| Monocytes | 1 | 2013 | 156 | 0.110 |
Why?
| Tumor Suppressor Proteins | 1 | 2013 | 141 | 0.110 |
Why?
| Virus Assembly | 1 | 2012 | 5 | 0.110 |
Why?
| Gene Order | 1 | 2012 | 18 | 0.110 |
Why?
| Disease Models, Animal | 1 | 2018 | 1647 | 0.110 |
Why?
| Deoxycytidine | 1 | 2012 | 28 | 0.100 |
Why?
| Gene Expression Regulation, Viral | 1 | 2012 | 50 | 0.100 |
Why?
| Antimetabolites, Antineoplastic | 1 | 2012 | 39 | 0.100 |
Why?
| Neoplasms | 2 | 2012 | 1322 | 0.100 |
Why?
| Dendritic Cells | 1 | 2012 | 142 | 0.100 |
Why?
| Immunity, Innate | 1 | 2012 | 114 | 0.100 |
Why?
| Ependyma | 1 | 2010 | 1 | 0.100 |
Why?
| Tumor Virus Infections | 1 | 2011 | 43 | 0.100 |
Why?
| Melanoma, Experimental | 1 | 2011 | 49 | 0.100 |
Why?
| Sirolimus | 1 | 2011 | 65 | 0.100 |
Why?
| Neoplasm Proteins | 1 | 2013 | 360 | 0.090 |
Why?
| Immunotherapy, Adoptive | 1 | 2011 | 134 | 0.090 |
Why?
| Macrophage Activation | 1 | 2009 | 29 | 0.090 |
Why?
| Epithelium, Corneal | 1 | 2008 | 10 | 0.080 |
Why?
| Organ Culture Techniques | 1 | 2008 | 53 | 0.080 |
Why?
| Pancreatic Neoplasms | 1 | 2012 | 234 | 0.080 |
Why?
| Plasmids | 1 | 2009 | 180 | 0.080 |
Why?
| Green Fluorescent Proteins | 1 | 2008 | 110 | 0.080 |
Why?
| Organ Specificity | 1 | 2008 | 126 | 0.080 |
Why?
| Herpes Simplex | 1 | 2008 | 24 | 0.080 |
Why?
| Chickens | 1 | 2008 | 118 | 0.080 |
Why?
| Ganglia, Spinal | 1 | 2008 | 50 | 0.080 |
Why?
| Immunotherapy | 1 | 2010 | 264 | 0.080 |
Why?
| Foot | 1 | 2008 | 50 | 0.080 |
Why?
| DNA, Viral | 1 | 2008 | 143 | 0.080 |
Why?
| Brain Neoplasms | 1 | 2011 | 285 | 0.080 |
Why?
| Spinal Cord | 1 | 2008 | 153 | 0.080 |
Why?
| Proteomics | 1 | 2009 | 343 | 0.070 |
Why?
| Survival Rate | 1 | 2009 | 954 | 0.070 |
Why?
| Macrophages | 1 | 2009 | 404 | 0.070 |
Why?
| Diabetes Mellitus | 1 | 2008 | 309 | 0.060 |
Why?
| Brain | 1 | 2010 | 1392 | 0.050 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2012 | 176 | 0.050 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2012 | 435 | 0.040 |
Why?
| Immunity | 1 | 2018 | 37 | 0.040 |
Why?
| Biological Evolution | 1 | 2018 | 37 | 0.040 |
Why?
| Immune System | 1 | 2018 | 49 | 0.040 |
Why?
| Mice, Inbred C57BL | 2 | 2011 | 2001 | 0.030 |
Why?
| DNA, Recombinant | 1 | 2014 | 17 | 0.030 |
Why?
| Cell Count | 1 | 2014 | 181 | 0.030 |
Why?
| Killer Cells, Natural | 1 | 2014 | 106 | 0.030 |
Why?
| Gene Duplication | 1 | 2013 | 17 | 0.030 |
Why?
| Interferon Type I | 1 | 2013 | 30 | 0.030 |
Why?
| Disease Susceptibility | 1 | 2013 | 95 | 0.030 |
Why?
| Sequence Alignment | 1 | 2013 | 146 | 0.030 |
Why?
| Bayes Theorem | 1 | 2013 | 125 | 0.030 |
Why?
| Genome | 1 | 2013 | 74 | 0.030 |
Why?
| Toll-Like Receptor 7 | 1 | 2012 | 4 | 0.030 |
Why?
| Chloroquine | 1 | 2012 | 12 | 0.030 |
Why?
| Microscopy, Electron, Transmission | 1 | 2012 | 87 | 0.030 |
Why?
| Phylogeny | 1 | 2013 | 269 | 0.030 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2012 | 40 | 0.030 |
Why?
| Dogs | 1 | 2012 | 216 | 0.030 |
Why?
| Interferon-alpha | 1 | 2012 | 50 | 0.030 |
Why?
| Luminescent Measurements | 1 | 2012 | 18 | 0.030 |
Why?
| T-Lymphocytes | 1 | 2014 | 374 | 0.030 |
Why?
| Amino Acid Sequence | 1 | 2013 | 767 | 0.030 |
Why?
| Cell Death | 1 | 2012 | 223 | 0.030 |
Why?
| Recombinant Proteins | 1 | 2013 | 570 | 0.030 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 153 | 0.020 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2012 | 219 | 0.020 |
Why?
| Mice, Nude | 1 | 2012 | 284 | 0.020 |
Why?
| Microscopy, Fluorescence | 1 | 2012 | 198 | 0.020 |
Why?
| Injections, Intraventricular | 1 | 2010 | 14 | 0.020 |
Why?
| Melanoma | 1 | 2014 | 313 | 0.020 |
Why?
| Blotting, Western | 1 | 2012 | 684 | 0.020 |
Why?
| Histocytochemistry | 1 | 2010 | 46 | 0.020 |
Why?
| Membrane Glycoproteins | 1 | 2012 | 270 | 0.020 |
Why?
| Down-Regulation | 1 | 2012 | 388 | 0.020 |
Why?
| Phosphorylation | 1 | 2012 | 613 | 0.020 |
Why?
| Genes, Reporter | 1 | 2010 | 98 | 0.020 |
Why?
| Luminescent Proteins | 1 | 2010 | 66 | 0.020 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2011 | 116 | 0.020 |
Why?
| Microscopy | 1 | 2010 | 66 | 0.020 |
Why?
| Cell Proliferation | 1 | 2014 | 1097 | 0.020 |
Why?
| Staining and Labeling | 1 | 2010 | 106 | 0.020 |
Why?
| Two-Hybrid System Techniques | 1 | 2009 | 26 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2012 | 693 | 0.020 |
Why?
| Virion | 1 | 2009 | 19 | 0.020 |
Why?
| Cell Survival | 1 | 2012 | 657 | 0.020 |
Why?
| Myeloid Cells | 1 | 2009 | 38 | 0.020 |
Why?
| Clinical Trials as Topic | 1 | 2012 | 491 | 0.020 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 2009 | 69 | 0.020 |
Why?
| Genome, Viral | 1 | 2009 | 100 | 0.020 |
Why?
| Cells, Cultured | 1 | 2013 | 1737 | 0.020 |
Why?
| Flow Cytometry | 1 | 2012 | 547 | 0.020 |
Why?
| Mice, Knockout | 1 | 2011 | 927 | 0.020 |
Why?
| Antigens, CD | 1 | 2009 | 242 | 0.020 |
Why?
| Gene Expression | 1 | 2010 | 664 | 0.020 |
Why?
| NF-kappa B | 1 | 2009 | 336 | 0.020 |
Why?
| Up-Regulation | 1 | 2009 | 509 | 0.020 |
Why?
| Mutation | 1 | 2013 | 1504 | 0.020 |
Why?
| Apoptosis | 1 | 2012 | 1302 | 0.020 |
Why?
| Female | 2 | 2013 | 28471 | 0.010 |
Why?
|
|
Liu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|